GALT Galectin Therapeutics Inc.

Fundamentals / CIK 0001133416 / USD

Galectin Therapeutics Inc. reported $13.01M in total assets and a net loss of $23.19M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GALT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$43.99MFY 2016 Net Income: -$21.44M2016FY 2017 Net Income: -$16.23M2017FY 2018 Net Income: -$13.90M2018FY 2019 Net Income: -$13.29M2019FY 2020 Net Income: -$23.46M2020FY 2021 Net Income: -$30.53M2021FY 2022 Net Income: -$38.78M2022FY 2023 Net Income: -$41.07M2023FY 2024 Net Income: -$47.05M2024FY 2025 Net Income: -$30.84M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $14.29M $36.57M $32.13M $31.74M $23.82M $17.98M $7.47M $6.47M $11.72M $15.32M
Total Operating Expenses $20.09M $42.43M $38.07M $38.35M $30.18M $23.44M $13.44M $13.60M $16.25M $21.48M
Operating Income -$20.09M -$42.43M -$38.07M -$38.35M -$30.18M -$23.44M -$13.44M -$13.60M -$16.25M -$21.48M
EBITDA -- -$42.43M -$38.07M -$38.35M -$30.18M -$23.44M -$13.44M -$13.60M -$16.25M -$21.47M
Interest Income $126K $338K $230K $52K $3.0K $66K $231K $38K $24K $45K
Interest Expense $7.33M $5.54M $2.79M $1.03M $489K $87K $87K $336K $12K --
Income Tax Expense $0 $0 -- -- -- -- -- -- -- --
Net Income -$30.84M -$47.05M -$41.07M -$38.78M -$30.53M -$23.46M -$13.29M -$13.90M -$16.23M -$21.44M
Basic EPS -$0.48 -$0.76 -$0.74 -$0.65 -$0.52 -$0.41 -$0.39 -$0.38 -$0.49 -$0.76
Diluted EPS -$0.48 -$0.76 -$0.74 -$0.65 -$0.52 -$0.41 -$0.39 -$0.38 -$0.49 -$0.76
Basic Shares Outstanding 63.9M 62.3M 60.2M 59.4M 58.5M 57.0M 52.2M 39.4M 35.5M 29.2M
Diluted Shares Outstanding 63.9M 62.3M 60.2M 59.4M 58.5M 57.0M 52.2M 39.4M 35.5M 29.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.56M $2.13M $2.23M $1.93M $2.61M $3.26M $6.49M $11.11M
Total Operating Expenses $3.37M $3.98M $4.08M $3.37M $4.20M $4.62M $7.90M $12.43M
Operating Income -$3.37M -$3.98M -$4.08M -$3.37M -$4.20M -$4.62M -$7.90M -$12.43M
Interest Income $28K $28K $36K $25K $39K $26K $35K $84K
Interest Expense $786K $2.00M $1.99M $1.94M $1.82M $1.83M $1.74M $1.73M
Net Income -$3.53M -$9.11M -$5.05M -$5.50M -$8.18M -$7.52M -$9.63M -$11.97M
Basic EPS -$0.04 -$0.14 -$0.08 -- -$0.13 -$0.12 -$0.15 --
Diluted EPS -$0.04 -$0.14 -$0.08 -- -$0.13 -$0.12 -$0.15 --
Basic Shares Outstanding 89.6M 65.9M 65.8M -- 64.2M 63.4M 63.2M --
Diluted Shares Outstanding 89.6M 65.9M 65.8M -- 64.2M 63.4M 63.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $17.72M $15.12M $25.66M $18.59M $39.65M $27.14M $47.48M $8.25M $3.05M $15.36M
Cash & Short-Term Investments $17.72M $15.12M $25.66M $18.59M $39.65M $27.14M $47.48M $8.25M $3.05M $15.36M
Total Current Assets $19.44M $17.25M $27.71M $20.55M $41.82M $29.46M $48.21M $8.83M $3.82M $15.79M
Property, Plant & Equipment, Net $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Intangible Assets -- -- -- -- -- -- -- $0 $0 $1.0K
Other Non-Current Assets $96K $243K $490K $733K $7.0K $135K $258K $174K $342K --
Total Non-Current Assets $96K $243K $490K $733K $7.0K $135K $258K $174K $342K $1.0K
Total Assets $19.53M $17.50M $28.20M $21.29M $41.83M $29.60M $48.47M $9.01M $4.16M $15.79M
Accounts Payable $3.25M $5.66M $6.43M $3.89M $1.80M $1.29M $1.66M $297K $608K $910K
Total Current Liabilities $8.03M $35.41M $15.68M $13.01M $9.03M $5.40M $2.82M $2.11M $2.97M $3.78M
Other Non-Current Liabilities $0 $0 $20K $66K $0 $8.0K $52K $0 -- --
Total Non-Current Liabilities $137.7M $85.16M $72.77M $40.47M $30.18M $8.0K $52K $0 $0 $0
Total Liabilities $145.7M $120.6M $88.44M $53.48M $39.21M $5.41M $2.87M $2.11M $2.97M $3.78M
Total Debt (incl. Leases) $22K $19K $66K $106K $8.0K $52K $90K -- -- --
Common Stock $65K $62K $61K $59K $59K $56K $56K $41K $36K $33K
Retained Earnings -$432.5M -$401.6M -$354.4M -$309.6M -$270.7M -$240.0M -$216.4M -$196.2M -$181.2M -$163.7M
Total Stockholders' Equity -$127.9M -$104.8M -$61.96M -$33.92M $893K $22.47M $43.87M $5.17M -$530K $10.29M
Total Equity -$127.9M -$104.8M -$61.96M -$33.92M $893K $22.47M $43.87M $5.17M -$530K $10.29M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $11.71M $13.27M $14.11M $17.72M $11.53M $13.77M $7.43M $15.12M
Cash & Short-Term Investments $11.71M $13.27M $14.11M $17.72M $11.53M $13.77M $7.43M $15.12M
Total Current Assets $12.90M $14.66M $15.69M $19.44M $12.73M $15.43M $9.29M $17.25M
Property, Plant & Equipment, Net -- -- -- $0 -- -- -- $0
Other Non-Current Assets $104K $167K $68K $96K $136K $175K $243K $243K
Total Non-Current Assets $104K $167K $68K $96K $136K $175K $243K $243K
Total Assets $13.01M $14.83M $15.76M $19.53M $12.87M $15.60M $9.53M $17.50M
Accounts Payable $3.50M $3.73M $3.12M $3.25M $5.39M $5.87M $6.53M $5.66M
Total Current Liabilities $46.41M $151.6M $7.31M $8.03M $136.4M $10.77M $110.8M $35.41M
Other Non-Current Liabilities $42K $59K -- $0 -- -- -- $0
Total Non-Current Liabilities $42K $59K $138.7M $137.7M $0 $122.0M $10.95M $85.16M
Total Liabilities $46.45M $151.7M $146.0M $145.7M $136.4M $132.8M $121.8M $120.6M
Total Debt (incl. Leases) $104K $118K $6.0K $22K $37K $52K $68K $19K
Common Stock $100K $66K $65K $65K $64K $63K $63K $62K
Retained Earnings -$450.4M -$446.8M -$437.6M -$432.5M -$427.0M -$418.8M -$411.2M -$401.6M
Total Stockholders' Equity -$35.16M -$139K -$132.0M -$127.9M -$125.3M -$118.9M -$114.0M -$104.8M
Total Equity -$35.16M -$139K -$132.0M -$127.9M -$125.3M -$118.9M -$114.0M -$104.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$30.84M -$47.05M -$41.07M -$38.78M -$30.53M -$23.46M -$13.29M -$13.90M -$16.23M -$21.44M
Depreciation & Amortization -- $0 $0 $0 $0 $0 $0 $0 $1.0K $7.0K
Stock-Based Compensation $1.66M $2.45M $2.26M $2.87M $2.08M $1.80M $1.68M $4.45M $1.10M $2.48M
Operating Cash Flow -$23.88M -$41.77M -$32.97M -$31.06M -$24.31M -$20.60M -$10.85M -$10.18M -$15.89M -$16.41M
Investing Cash Flow $0 $0 $0 $0 $0 $0 -- $0 $0 $0
Common Stock Issued $3.23M $0 -- $0 $6.81M $263K $50.47M $15.38M $3.58M $5.92M
Financing Cash Flow $26.48M $31.23M $40.03M $10.00M $36.81M $263K $50.08M $15.38M $3.58M $5.92M
Net Change in Cash $2.60M -$10.54M $7.07M -$21.06M $12.51M -$20.34M $39.23M $5.20M -$12.31M -$10.48M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.53M -$9.11M -$5.05M -$5.50M -$8.18M -$7.52M -$9.63M -$11.97M
Stock-Based Compensation $949K $963K $686K $195K $496K $500K $468K $590K
Operating Cash Flow -$2.27M -$2.44M -$3.87M -$6.04M -$3.54M -$6.60M -$7.69M -$12.79M
Financing Cash Flow $702K $1.60M $257K $12.24M $1.30M $12.94M $0 $851K
Net Change in Cash -$1.56M -$842K -$3.61M $6.20M -$2.25M $6.34M -$7.69M -$11.94M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -- -- -3418.5% -104.4% -30.3% -268.6% -- -208.3%
Return on Assets (ROA) -157.9% -268.9% -145.6% -182.2% -73.0% -79.3% -27.4% -154.3% -390.2% -135.7%
Current Ratio 2.42x 0.49x 1.77x 1.58x 4.63x 5.46x 17.10x 4.19x 1.29x 4.18x
Quick Ratio 2.21x 0.43x 1.64x 1.43x 4.39x 5.03x 16.84x 3.92x 1.03x 4.06x
Debt to Equity -- -- -- -- 0.01x 0.00x 0.00x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -178.3% -187.8% -166.6% -157.9% -290.0% -258.6% -474.3% -268.9%
Current Ratio 0.28x 0.10x 2.15x 2.42x 0.09x 1.43x 0.08x 0.49x
Quick Ratio 0.25x 0.09x 1.93x 2.21x 0.08x 1.28x 0.07x 0.43x
Source: SEC EDGAR CompanyFacts (CIK 0001133416) · from June 30, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal